Humanis Saglik Anonim Sirketi

This study checked if a new generic pill containing three diabetes medicines (empagliflozin, linagliptin, and metformin) works the same as the brand-name Trijardy XR. Fourteen healthy adults took a single dose of each version under fed conditions. The goal was to see if the gener…

This study checked if a generic version of a diabetes drug (ertugliflozin/metformin) works the same as the brand-name Segluromet. Thirty-six healthy adults took a single dose of each tablet under fed conditions. The goal was to see if the generic releases the same amount of medic…

This study tested whether a new version of the schizophrenia medication brexpiprazole gets into the bloodstream the same way as the already-approved version. It involved 36 healthy adults who took single doses of each drug. The goal was to see if the two versions are bioequivalen…

This study checked whether a generic version of the diabetes drug empagliflozin/metformin works the same as the brand-name Synjardy XR. Forty healthy adults took a single dose of each pill under fed conditions. The goal was to see if the generic matches the brand in how much drug…

This study tested whether a generic version of the diabetes drug Synjardy XR (empagliflozin/metformin) works the same as the brand-name version in the body. It involved 32 healthy adults who took a single dose of each version under fasting conditions. The goal was to check if the…

This study checked whether a new generic version of vonoprazan (20 mg) works the same as the brand-name drug Voquezna in 28 healthy adults. Participants took a single dose of each under fasting conditions, and blood tests showed the generic was absorbed at similar levels. The stu…

This study checked if a new generic tablet of bempedoic acid (a cholesterol-lowering drug) works the same as the brand-name version (Nilemdo). Thirty-two healthy adults took a single dose of each under fasting conditions. The goal was to see if the generic is absorbed into the bl…

This study tested whether a generic version of the blood thinner apixaban works the same as the brand-name drug. Thirty healthy adults took a single dose of each version, and researchers measured drug levels in their blood. The goal was to confirm the generic is equally effective…